UNRAVELING THE DUB NETWORK THAT CONTROLS DEATH RECEPTOR INDUCED CELL SURVIVAL AND DEATH PATHWAYS
解开控制死亡受体诱导的细胞存活和死亡途径的 DUB 网络
基本信息
- 批准号:414826869
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2018
- 资助国家:德国
- 起止时间:2017-12-31 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Appropriate control of programmed cell death (e.g. apoptosis and necroptosis) and survival underlies embryonal development, innate immunity and cancer surveillance. Disturbances in these cell fate checkpoints affect the inflammatory state of the cellular microenvironment, but the molecular mechanisms how cells decide and switch between death/survival pathways remain poorly understood.Tumour necrosis factor (TNF) receptor 1 (TNFR1) is a prototypical death receptor and a central node in mediating apoptotic, necroptotic and survival responses. Post-translational modification of downstream TNFR substrate proteins with linear (M1) and K63-linked ubiquitin chains is essential for controlling these checkpoints and survival/death switching. M1/K63, as well as other chain types, are tightly regulated by deubiquitinating enzymes (DUBs), such as CYLD, OTULIN and A20.The individual roles of CYLD, OTULIN and A20 on M1/K63 ubiquitin in cell death/survival are relatively well understood. However, the interplay of CYLD/OTULIN/A20 in regulating ubiquitin-dependent cell fate checkpoints and switching remains largely unclear. Furthermore, numerous key proteins involved in cell death/survival are ubiquitinated as well, but regulatory DUBs for these crucial ubiquitination events remain unidentified. Therefore, a systemic approach to understand the complex DUB interplay will reveal novel insights into the vital control of cell survival/death responses. Overall, this proposal aims to unravel the OTULIN/CYLD/A20 triad in controlling TNFR1-mediated survival and programmed cell death pathways in mammalian cells and to investigate the contribution of additional DUBs on cell fate switching.The outcome of this proposal is expected to gain important novel insights in the fields of programmed cell death, innate immunology, infections and tumour formation. As a consequence, understanding the fundamental roles of ubiquitination in cell death and survival pathways will directly impact our understanding of human disease.
适当控制程序性细胞死亡(例如凋亡和坏死性凋亡)和存活是胚胎发育、先天免疫和癌症监测的基础。肿瘤坏死因子(TNF)受体1(TNFR 1)是一种典型的死亡受体,是介导细胞凋亡、坏死性凋亡和存活反应的中心节点。翻译后修饰的下游TNFR底物蛋白与线性(M1)和K63连接的泛素链是必不可少的控制这些检查点和生存/死亡开关。M1/K63以及其他链类型受到去泛素化酶(DUBs)如CYLD、OTULIN和A20的严格调控。CYLD、OTULIN和A20对M1/K63泛素在细胞死亡/存活中的单独作用相对较好地理解。然而,CYLD/OTULIN/A20在调节泛素依赖性细胞命运检查点和转换中的相互作用在很大程度上仍不清楚。此外,许多参与细胞死亡/存活的关键蛋白也被泛素化,但这些关键泛素化事件的调节DUB仍然未被确定。因此,了解复杂DUB相互作用的系统方法将揭示对细胞存活/死亡反应的重要控制的新见解。总体而言,该提案旨在解开OTULIN/CYLD/A20三联体在控制哺乳动物细胞中TNFR 1介导的存活和程序性细胞死亡途径中的作用,并研究额外DUB对细胞命运转换的贡献,该提案的结果有望在程序性细胞死亡,先天免疫学,感染和肿瘤形成等领域获得重要的新见解。因此,了解泛素化在细胞死亡和存活途径中的基本作用将直接影响我们对人类疾病的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Privatdozent Dr. Sjoerd van Wijk其他文献
Privatdozent Dr. Sjoerd van Wijk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Privatdozent Dr. Sjoerd van Wijk', 18)}}的其他基金
Decrypting the USP22-homologous DUB network to sensitize pancreatic cancer for STING-mediated necroptosis
解密 USP22 同源 DUB 网络以使胰腺癌对 STING 介导的坏死性凋亡敏感
- 批准号:
426710085 - 财政年份:
- 资助金额:
-- - 项目类别:
Research Grants
Investigating the role of OTULIN and the regulation of linear ubiquitination in the pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma
研究 OTULIN 的作用和线性泛素化在活化 B 细胞样弥漫性大 B 细胞淋巴瘤发病机制中的调节
- 批准号:
494877499 - 财政年份:
- 资助金额:
-- - 项目类别:
Research Grants
相似国自然基金
人类疱疹病毒去泛素化酶(DUB)干扰宿主天然免疫等重要信号通路的研究
- 批准号:81371795
- 批准年份:2013
- 资助金额:100.0 万元
- 项目类别:面上项目
人类新发冠状病毒编码DUB抑制宿主干扰素抗病毒天然免疫反应分子机制
- 批准号:30972761
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
冠状病毒PLP蛋白酶去泛素酶(DUB)特性及其对p53-PML通路调节作用机制
- 批准号:30870536
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
REU Site: The DUB REU Program for Human-Centered Computing Research
REU 网站:DUB REU 以人为中心的计算研究计划
- 批准号:
2348926 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Estabulishment of synthetic lethality of head and neck squamous cell carcinoma via DUB and development of novel therapeutic strategy
DUB 头颈鳞状细胞癌综合致死率的建立及新治疗策略的开发
- 批准号:
20KK0378 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia
阐明 USP16 功能并探讨其在唐氏综合症白血病中的 DUB 活性
- 批准号:
10559582 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Mechanisms of reversible DUB oxidation in genome stability pathways - Revision
基因组稳定性途径中可逆 DUB 氧化的机制 - 修订版
- 批准号:
10174167 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Novel Screening Platform for Discovery of DUB Targeting Probes
用于发现 DUB 靶向探针的新型筛选平台
- 批准号:
9816851 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Novel Screening Platform for Discovery of DUB Targeting Probes
用于发现 DUB 靶向探针的新型筛选平台
- 批准号:
10166601 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Novel Screening Platform for Discovery of DUB Targeting Probes
用于发现 DUB 靶向探针的新型筛选平台
- 批准号:
10396625 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Construction of DUB MAP for innate immune and inflammatory responses
构建先天免疫和炎症反应的 DUB MAP
- 批准号:
19K22541 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Interaction between a bacterial DUB and human host proteins
细菌 DUB 与人类宿主蛋白之间的相互作用
- 批准号:
510699-2017 - 财政年份:2017
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards